(NASDAQ: ALGN) Align Technology's forecast annual revenue growth rate of 6.08% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.08%.
Align Technology's revenue in 2026 is $3,982,622,000.On average, 20 Wall Street analysts forecast ALGN's revenue for 2026 to be $304,937,478,750, with the lowest ALGN revenue forecast at $287,573,979,960, and the highest ALGN revenue forecast at $323,951,227,425. On average, 19 Wall Street analysts forecast ALGN's revenue for 2027 to be $319,000,477,770, with the lowest ALGN revenue forecast at $296,040,479,370, and the highest ALGN revenue forecast at $342,821,476,110.
In 2028, ALGN is forecast to generate $348,920,225,685 in revenue, with the lowest revenue forecast at $324,740,477,370 and the highest revenue forecast at $370,445,224,185.